Investment Thesis for Kite Pharma, Inc. (Nasdaq: KITE)

Abstract

This working paper is an in-depth analysis of Kite Pharma, Inc. The analysis examines the economic factors that impact Kite Pharma’s underlying business fundamentals. This analysis is then combined with a proprietary Discounted Cash Flow (P-DCF) model to determine Kite Pharma's financial position. The model will be presented along-side Monte-Carlo simulations to reveal the distribution of probable free cash flows and the potential for future earnings. In addition to these quantitative factors, we I assess the alignment of Kite Pharma’s executives with shareholders based on the company’s proxy report. At the conclusion of this analysis, I aim to clearly convey Kite Pharma’s business strategy and the company’s financial standing to arrive at a sound investment decision.